Nishijima Takeshi, Yazaki Hirohisa, Hinoshita Fumihiko, Tasato Daisuke, Hoshimoto Kazufusa, Teruya Katsuji, Gatanaga Hiroyuki, Kikuchi Yoshimi, Oka Shinichi
AIDS Clinical Center, National Center for Global Health and Medicine, Japan.
Intern Med. 2012;51(17):2469-71. doi: 10.2169/internalmedicine.51.7766. Epub 2012 Sep 1.
We describe a case of 68-year-old Japanese man with HIV-1 infection who developed acute kidney injury with prominent tubular dysfunction immediately after starting tenofovir-containing antiretroviral therapy. Antiretroviral therapy was discontinued in two weeks but renal function, as well as tubular function, did not shown full recovery even at a 3-year follow-up examination. Acute tubular necrosis, a rare but well-known side effect of tenofovir, was suspected, but kidney biopsy confirmed interstitial nephritis. It is important to distinguish drug-induced interstitial nephritis from acute tubular necrosis, because early steroid administration can improve renal dysfunction caused by acute interstitial nephritis.
我们描述了一例68岁的日本男性HIV-1感染者,在开始含替诺福韦的抗逆转录病毒治疗后立即出现急性肾损伤,并伴有明显的肾小管功能障碍。抗逆转录病毒治疗在两周后停用,但即使在3年的随访检查中,肾功能以及肾小管功能仍未完全恢复。怀疑是替诺福韦罕见但众所周知的副作用急性肾小管坏死,但肾活检证实为间质性肾炎。区分药物性间质性肾炎和急性肾小管坏死很重要,因为早期给予类固醇可以改善急性间质性肾炎引起的肾功能障碍。